Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression
出版年份 2021 全文链接
标题
Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression
作者
关键词
Depression, Antidepressant, Rapid-acting, Glutamatergic modulator, Synaptic plasticity
出版物
PHARMACOLOGICAL RESEARCH
Volume 171, Issue -, Pages 105761
出版商
Elsevier BV
发表日期
2021-07-07
DOI
10.1016/j.phrs.2021.105761
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
- (2021) Ioline D. Henter et al. CNS DRUGS
- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Are we repeating mistakes of the past? A review of the evidence for esketamine
- (2020) Mark A. Horowitz et al. BRITISH JOURNAL OF PSYCHIATRY
- A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression
- (2020) Lawrence T Park et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents
- (2020) Molly C. Kalmoe et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- (2R,6R)-hydroxynorketamine exerts mGlu2receptor-dependent antidepressant actions
- (2019) Panos Zanos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function
- (2019) Eric W. Lumsden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice
- (2019) James Francescangeli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue
- (2019) Daniela Enache et al. BRAIN BEHAVIOR AND IMMUNITY
- Keeping up with the clinical advances: depression
- (2019) Renee-Marie Ragguett et al. CNS SPECTRUMS
- An update on NMDA antagonists in depression
- (2019) Bartłomiej Pochwat et al. Expert Review of Neurotherapeutics
- (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism
- (2019) Yukio Ago et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
- (2019) Chun Yang et al. Translational Psychiatry
- Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms
- (2019) Taro Kato et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine-based anesthesia improves electroconvulsive therapy outcomes: a randomized-controlled study
- (2018) Jonathan J. Gamble et al. Canadian Journal of Anesthesia-Journal canadien d anesthesie
- Convergent Mechanisms Underlying Rapid Antidepressant Action
- (2018) Panos Zanos et al. CNS DRUGS
- Mechanisms of ketamine action as an antidepressant
- (2018) P Zanos et al. MOLECULAR PSYCHIATRY
- Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of ( R,S )-ketamine and ( S )-ketamine, but not ( R )-ketamine
- (2018) Zheng Tian et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Astroglial Glutamate Signaling and Uptake in the Hippocampus
- (2018) Christine R. Rose et al. Frontiers in Molecular Neuroscience
- A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems
- (2018) Samuel T. Wilkinson et al. DRUG DISCOVERY TODAY
- Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date
- (2018) Renee-Marie Ragguett et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- An update on ketamine and its two enantiomers as rapid-acting antidepressants
- (2018) Kai Zhang et al. Expert Review of Neurotherapeutics
- Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-like Effects
- (2018) John E Donello et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
- (2018) Sho Moriguchi et al. MOLECULAR PSYCHIATRY
- Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
- (2018) Caroline Madeira et al. Frontiers in Psychiatry
- Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial
- (2017) James W. Murrough et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?
- (2017) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
- (2017) M Kokkinou et al. MOLECULAR PSYCHIATRY
- Targeting glutamate signalling in depression: progress and prospects
- (2017) James W. Murrough et al. NATURE REVIEWS DRUG DISCOVERY
- Involvement of extracellular signal-regulated kinase (ERK) in the short and long-lasting antidepressant-like activity of NMDA receptor antagonists (zinc and Ro 25-6981) in the forced swim test in rats
- (2017) Bartłomiej Pochwat et al. NEUROPHARMACOLOGY
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial
- (2017) Jerome H Taylor et al. NEUROPSYCHOPHARMACOLOGY
- New targets for rapid antidepressant action
- (2017) Rodrigo Machado-Vieira et al. PROGRESS IN NEUROBIOLOGY
- Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression
- (2017) Charles R. Conway et al. JAMA Psychiatry
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
- (2017) Gerard Sanacora et al. JAMA Psychiatry
- Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
- (2017) Chun Yang et al. Translational Psychiatry
- GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice
- (2016) Lakshmi Rajagopal et al. BEHAVIOURAL BRAIN RESEARCH
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Ketamine abuse potential and use disorder
- (2016) Yu Liu et al. BRAIN RESEARCH BULLETIN
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
- (2016) Marko A. Peltoniemi et al. CLINICAL PHARMACOKINETICS
- Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
- (2016) Brittany Jaso et al. Current Neuropharmacology
- Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
- (2016) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- AVP-786 for the treatment of agitation in dementia of the Alzheimer’s type
- (2016) Ricardo P. Garay et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial
- (2016) Morteza Jafarinia et al. JOURNAL OF AFFECTIVE DISORDERS
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
- (2016) Ronald S Duman et al. NATURE MEDICINE
- Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study
- (2016) Gerard Sanacora et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy and safety of an adjunctive mGlu2 receptor positive allosteric modulator to a SSRI/SNRI in anxious depression
- (2016) Justine M. Kent et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Role of calcium, glutamate and NMDA in major depression and therapeutic application
- (2016) Lorenz Deutschenbaur et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review
- (2016) Matthew D. Cooper et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression
- (2016) Jorge A. Quiroz et al. JAMA Psychiatry
- Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test
- (2015) Phil Skolnick et al. ACTA NEUROPSYCHIATRICA
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
- (2015) Chadi G. Abdallah et al. Annual Review of Medicine
- Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice
- (2015) Linda Nguyen et al. BEHAVIOURAL BRAIN RESEARCH
- Illness Progression, Recent Stress, and Morphometry of Hippocampal Subfields and Medial Prefrontal Cortex in Major Depression
- (2015) Michael T. Treadway et al. BIOLOGICAL PSYCHIATRY
- Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders
- (2015) Y. Ohgi et al. CURRENT MOLECULAR MEDICINE
- The use of ketamine as an antidepressant: a systematic review and meta-analysis
- (2015) Caoimhe M. Coyle et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
- (2015) Ying Xu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Single-Dose Ketamine Followed by Daily d-Cycloserine in Treatment-Resistant Bipolar Depression
- (2015) Joshua T. Kantrowitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- Activity-Dependent Rapid Local RhoA Synthesis Is Required for Hippocampal Synaptic Plasticity
- (2015) V. Briz et al. JOURNAL OF NEUROSCIENCE
- Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent
- (2015) SHELDON PRESKORN et al. Journal of Psychiatric Practice
- Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
- (2015) G I Papakostas et al. MOLECULAR PSYCHIATRY
- The Genetics of Stress-Related Disorders: PTSD, Depression and Anxiety Disorders
- (2015) Jordan W Smoller NEUROPSYCHOPHARMACOLOGY
- The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus
- (2015) J. Burgdorf et al. NEUROSCIENCE
- The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: Central mediators of pathophysiology and antidepressant activity?
- (2015) Florian Freudenberg et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression
- (2015) Bruno Romeo et al. PSYCHIATRY RESEARCH
- Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
- (2015) J. W. Murrough et al. PSYCHOLOGICAL MEDICINE
- Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test
- (2015) Phil Skolnick et al. ACTA NEUROPSYCHIATRICA
- Large-Scale Network Dysfunction in Major Depressive Disorder
- (2015) Roselinde H. Kaiser et al. JAMA Psychiatry
- EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT-RESISTANT DEPRESSION
- (2014) Rebecca B. Price et al. DEPRESSION AND ANXIETY
- The utility of the combination of dextromethorphan and quinidine in the treatment of bipolar II and bipolar NOS
- (2014) Tammas Frederick Kelly et al. JOURNAL OF AFFECTIVE DISORDERS
- REDD1 is essential for stress-induced synaptic loss and depressive behavior
- (2014) Kristie T Ota et al. NATURE MEDICINE
- Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders
- (2014) Matthew P. Parsons et al. NEURON
- The Role of GluN2A and GluN2B Subunits on the Effects of NMDA Receptor Antagonists in Modeling Schizophrenia and Treating Refractory Depression
- (2014) Laura Jiménez-Sánchez et al. NEUROPSYCHOPHARMACOLOGY
- Organization, control and function of extrasynaptic NMDA receptors
- (2014) T. Papouin et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
- (2014) A. McGirr et al. PSYCHOLOGICAL MEDICINE
- Hippocampal structural and functional changes associated with electroconvulsive therapy response
- (2014) C C Abbott et al. Translational Psychiatry
- Is There a Path Forward for mGlu2 Positive Allosteric Modulators for the Treatment of Schizophrenia?
- (2013) Corey R. Hopkins ACS Chemical Neuroscience
- Nitrous Oxide for the Management of Labor Pain
- (2013) Frances E. Likis et al. ANESTHESIA AND ANALGESIA
- New paradigms for treatment-resistant depression
- (2013) Carlos Zarate et al. Annals of the New York Academy of Sciences
- Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression
- (2013) Chih-Chia Huang et al. BIOLOGICAL PSYCHIATRY
- From Pathophysiology to Novel Antidepressant Drugs: Glial Contributions to the Pathology and Treatment of Mood Disorders
- (2013) Gerard Sanacora et al. BIOLOGICAL PSYCHIATRY
- Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
- (2013) John H. Krystal et al. BIOLOGICAL PSYCHIATRY
- GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists
- (2013) Joseph R Moskal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- mGluR2 positive allosteric modulators: a patent review (2009 – present)
- (2013) Andrés A Trabanco et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder
- (2013) Mark J. Niciu et al. JOURNAL OF NEURAL TRANSMISSION
- Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats
- (2013) Wei-Li Zhu et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
- (2013) G Sanacora et al. MOLECULAR PSYCHIATRY
- GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
- (2013) Jeffrey Burgdorf et al. NEUROPSYCHOPHARMACOLOGY
- Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests
- (2013) Jesper T. Andreasen et al. NEUROSCIENCE LETTERS
- Neuronal plasticity and antidepressant actions
- (2013) Eero Castrén et al. TRENDS IN NEUROSCIENCES
- Vitamin D Supplementation and Depression in the Women's Health Initiative Calcium and Vitamin D Trial
- (2012) E. R. Bertone-Johnson et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Ketamine for Depression: Where Do We Go from Here?
- (2012) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- The Action of Antidepressants on the Glutamate System: Regulation of Glutamate Release and Glutamate Receptors
- (2012) Laura Musazzi et al. BIOLOGICAL PSYCHIATRY
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects
- (2012) Vanja Duric et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A randomized add-on trial of high-dose d-cycloserine for treatment-resistant depression
- (2012) Uriel Heresco-Levy et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder
- (2012) Sheng-Yu Lee et al. JOURNAL OF AFFECTIVE DISORDERS
- Neuropsychological and mood effects of ketamine in electroconvulsive therapy: A randomised controlled trial
- (2012) Colleen K. Loo et al. JOURNAL OF AFFECTIVE DISORDERS
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan
- (2012) Edward C. Lauterbach MEDICAL HYPOTHESES
- Decreased expression of synapse-related genes and loss of synapses in major depressive disorder
- (2012) Hyo Jung Kang et al. NATURE MEDICINE
- Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators
- (2012) Daniel T. Monaghan et al. NEUROCHEMISTRY INTERNATIONAL
- Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression
- (2012) Z.A. Hughes et al. NEUROPHARMACOLOGY
- Synaptic plasticity in depression: Molecular, cellular and functional correlates
- (2012) W.N. Marsden PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- A pivotal role of GSK-3 in synaptic plasticity
- (2012) Clarrisa A. Bradley et al. Frontiers in Molecular Neuroscience
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- Signalling pathways underlying structural plasticity of dendritic spines
- (2011) Michael Patterson et al. BRITISH JOURNAL OF PHARMACOLOGY
- Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
- (2011) Surendra P. Singh et al. CNS DRUGS
- Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo
- (2011) Matthew J. Robson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department
- (2011) Gregory Luke Larkin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Dextromethorphan as a potential rapid-acting antidepressant
- (2011) Edward C. Lauterbach MEDICAL HYPOTHESES
- Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
- (2011) E Beurel et al. MOLECULAR PSYCHIATRY
- The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
- (2011) Maurizio Popoli et al. NATURE REVIEWS NEUROSCIENCE
- Stress and anxiety: Structural plasticity and epigenetic regulation as a consequence of stress
- (2011) Bruce S. McEwen et al. NEUROPHARMACOLOGY
- Towards a glutamate hypothesis of depression
- (2011) Gerard Sanacora et al. NEUROPHARMACOLOGY
- Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression
- (2011) Lobna Ibrahim et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
- (2011) Courtney S. Jernigan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Translating Glutamate: From Pathophysiology to Treatment
- (2011) D. C. Javitt et al. Science Translational Medicine
- Linking Molecules to Mood: New Insight Into the Biology of Depression
- (2010) Vaishnav Krishnan et al. AMERICAN JOURNAL OF PSYCHIATRY
- Biologic Effects of Nitrous Oxide
- (2010) Robert D. Sanders et al. ANESTHESIOLOGY
- Taming the Ketamine Tiger
- (2010) Edward F. Domino ANESTHESIOLOGY
- Structure of theMycobacterium tuberculosisd-Alanine:d-Alanine Ligase, a Target of the Antituberculosis Drug d-Cycloserine
- (2010) John B. Bruning et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders
- (2010) Cagri Yüksel et al. BIOLOGICAL PSYCHIATRY
- Synaptic stability and plasticity in a floating world
- (2010) Kimberly Gerrow et al. CURRENT OPINION IN NEUROBIOLOGY
- Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine
- (2010) Kenji Hashimoto Expert Review of Neurotherapeutics
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
- (2010) Nancy DiazGranados et al. JOURNAL OF CLINICAL PSYCHIATRY
- The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?
- (2010) G MacQueen et al. MOLECULAR PSYCHIATRY
- The GABAergic deficit hypothesis of major depressive disorder
- (2010) B Luscher et al. MOLECULAR PSYCHIATRY
- A negative regulator of MAP kinase causes depressive behavior
- (2010) Vanja Duric et al. NATURE MEDICINE
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
- (2010) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Elucidating biological risk factors in suicide: Role of protein kinase A
- (2010) Yogesh Dwivedi et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Structural dynamics of dendritic spines in memory and cognition
- (2010) Haruo Kasai et al. TRENDS IN NEUROSCIENCES
- Glutamatergic Modulators: The Future of Treating Mood Disorders?
- (2010) Carlos Zarate et al. HARVARD REVIEW OF PSYCHIATRY
- Targeting glial physiology and glutamate cycling in the treatment of depression
- (2009) Gerald W. Valentine et al. BIOCHEMICAL PHARMACOLOGY
- Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
- (2009) Rebecca B. Price et al. BIOLOGICAL PSYCHIATRY
- Neurogranin enhances synaptic strength through its interaction with calmodulin
- (2009) Ling Zhong et al. EMBO JOURNAL
- Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action☆
- (2009) P.J. Lucassen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to anN-Methyl-D-Aspartate Antagonist
- (2009) Rodrigo Machado-Vieira et al. JOURNAL OF CLINICAL PSYCHIATRY
- NMDA Receptor GluN2B (GluR 2/NR2B) Subunit Is Crucial for Channel Function, Postsynaptic Macromolecular Organization, and Actin Cytoskeleton at Hippocampal CA3 Synapses
- (2009) K. Akashi et al. JOURNAL OF NEUROSCIENCE
- Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA Translation
- (2009) H. Jourdi et al. JOURNAL OF NEUROSCIENCE
- Neurocircuitry of Mood Disorders
- (2009) Joseph L Price et al. NEUROPSYCHOPHARMACOLOGY
- Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
- (2009) Jonathan Savitz et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity
- (2009) R. I. Stanika et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Journey through the K-hole: Phenomenological aspects of ketamine use
- (2008) L. Muetzelfeldt et al. DRUG AND ALCOHOL DEPENDENCE
- Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression
- (2008) Beata Karolewicz et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia
- (2008) PJ Harrison et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Plasticity-dependent changes in metabotropic glutamate receptor expression at excitatory hippocampal synapses
- (2008) Juliette E. Cheyne et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole
- (2008) M Banasr et al. MOLECULAR PSYCHIATRY
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
- (2008) Gerard Sanacora et al. NATURE REVIEWS DRUG DISCOVERY
- Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: Role of corticosterone-mediated apical dendritic atrophy
- (2008) R.-J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression
- (2008) Anteneh M. Feyissa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation